Austin-based neurotechnology Paradromics announced that it has received FDA approvals to start its clinical trials.

A Rhode Island biotech with a novel Alzheimer’s candidate has raised $30 million, hired a new CEO, and is preparing to move ...

Horsham-based clinical trial supply and services company Myonex is turning to a familiar face as its new leader.

A study found that Trump administration NIH grant cuts led to termination of 118 trials studying cancer, 97 studying ...

The National Institutes of Health has canceled funding for at least 383 clinical trials in the last year, affecting some ...

With the right technology and support, CRAs can continue their evolution into powerful agents of trial success that bridge ...

Grant funding disruptions affected about one in 30 trials, according to a research letter published online Nov. 17 in JAMA ...

AI in clinical trials offers significant opportunities by enhancing efficiency, reducing timelines, and enabling precision ...

The cancer center’s first test of the technology matched all of its manually identified clinical trials candidates and found ...

Crofelemer can potentially extend lives of MVID patients - infants and children who face the lethal natural history of the ...

Most kidney recipients remain on anti-rejection medication for life, but thanks to a clinical trial, a former firefighter is ...

The risks of this treatment need to be carefully explained, and subjects know that they could be assigned to an active treatment or a placebo if it is this type of trial. Some trials compare a new ...